InMed Pharmaceuticals Inc.·4

Dec 18, 11:59 AM ET

WOUDENBERG MICHAEL 4

4 · InMed Pharmaceuticals Inc. · Filed Dec 18, 2020

Insider Transaction Report

Form 4
Period: 2020-12-16
WOUDENBERG MICHAEL
VP, Chem/Manufacturing/Control
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2020-12-16+30,00030,000 total
    Exercise: $3.02Exp: 2025-12-15Common shares (30,000 underlying)
Footnotes (2)
  • [F1]The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00.
  • [F2]The options were granted on 12/16/2020 and will vest as follows: 25% on 6/16/2021; 25% on 12/16/2021; 25% on 6/16/2022; and 25% on 12/16/2022.

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT